Table 5.
Surgical Mortality
| 30 Day Mortality | 90 Day Mortality | |||
|---|---|---|---|---|
| No | Yes | No | Yes | |
| Received Panitumumab | ||||
| No | 57 (98%) | 1 (2%) | 57 (98%) | 1 (2%) |
| Yes | 32 (91%) | 3 (9%) | 31 (89%) | 4 (11%) |
| p-value† | 0.15 | 0.06 | ||
| Extended Resection | ||||
| Lobectomy | 76 (99%) | 1 (1%) | 75 (97%) | 2 (3%) |
| Extended resection | 13 (81%) | 3 (19%) | 13 (81%) | 3 (19%) |
| p-value† | 0.02 | 0.03 | ||
| RTOG 0839 RT Data | n=51 | n=3* | n=50 | n=4 |
| Lung V5 | ||||
| Median | 55.9 | 57.7, 64.0, 86.0* | 55.0 | 75.0 |
| Min-Max | 19.0-88.2 | 19.0-86.0 | 57.7-88.2 | |
| Q1-Q3 | 46.0-69.2 | 46.0-68.3 | 60.8-87.1 | |
| p-value‡ | 0.17 | 0.04 | ||
| Ipsilateral Lung V10 | ||||
| Median | 61.1 | 56.3, 65.9, 95.9* | 61.0 | 76.2 |
| Min-Max | 26.5-87.0 | 26.5-87.0 | 56.3-95.5 | |
| Q1-Q3 | 48.0-72.2 | 48.0-72.0 | 61.1-91.0 | |
| p-value† | 0.30 | 0.09 | ||
| Contralateral Lung V5 | ||||
| Median | 43.4 | 49.6, 55.6, 73.4* | 42.9 | 64.5 |
| Min-Max | 0.5-85.6 | 0.5-85.6 | 49.6-83.0 | |
| Q1-Q3 | 26.7-64.0 | 26.7-62.9 | 52.6-78.2 | |
| p-value‡ | 0.25 | 0.07 | ||
*
All three values reported, due to small number of events
†
Fisher’s exact test
‡
Wilcoxon rank sum test